Literature DB >> 29420686

Marginal false discovery rates for penalized regression models.

Patrick J Breheny1.   

Abstract

Penalized regression methods are an attractive tool for high-dimensional data analysis, but their widespread adoption has been hampered by the difficulty of applying inferential tools. In particular, the question "How reliable is the selection of those features?" has proved difficult to address. In part, this difficulty arises from defining false discoveries in the classical, fully conditional sense, which is possible in low dimensions but does not scale well to high-dimensional settings. Here, we consider the analysis of marginal false discovery rates (mFDRs) for penalized regression methods. Restricting attention to the mFDR permits straightforward estimation of the number of selections that would likely have occurred by chance alone, and therefore provides a useful summary of selection reliability. Theoretical analysis and simulation studies demonstrate that this approach is quite accurate when the correlation among predictors is mild, and only slightly conservative when the correlation is stronger. Finally, the practical utility of the proposed method and its considerable advantages over other approaches are illustrated using gene expression data from The Cancer Genome Atlas and genome-wide association study data from the Myocardial Applied Genomics Network.
© The Author 2018. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  False discovery rate; High-dimensional data analysis; Lasso; Penalized regression

Mesh:

Year:  2019        PMID: 29420686     DOI: 10.1093/biostatistics/kxy004

Source DB:  PubMed          Journal:  Biostatistics        ISSN: 1465-4644            Impact factor:   5.899


  6 in total

1.  Sign-based Shrinkage Based on an Asymmetric LASSO Penalty.

Authors:  Eric S Kawaguchi; Burcu F Darst; Kan Wang; David V Conti
Journal:  J Data Sci       Date:  2021-06-02

2.  Marginal false discovery rate for a penalized transformation survival model.

Authors:  Weijuan Liang; Shuangge Ma; Cunjie Lin
Journal:  Comput Stat Data Anal       Date:  2021-04-02       Impact factor: 2.035

3.  The Doubled-Edged Sword of T1-Mapping in Systemic Sclerosis-A Comparison with Infectious Myocarditis Using Cardiovascular Magnetic Resonance.

Authors:  George Markousis-Mavrogenis; Loukia Koutsogeorgopoulou; Gikas Katsifis; Theodoros Dimitroulas; Genovefa Kolovou; George D Kitas; Petros P Sfikakis; Sophie I Mavrogeni
Journal:  Diagnostics (Basel)       Date:  2020-05-24

4.  Cardiovascular magnetic resonance clarifies arrhythmogenicity in asymptomatic young athletes with ventricular arrhythmias undergoing pre-participation evaluation.

Authors:  George Markousis-Mavrogenis; Aikaterini Giannakopoulou; Nikolaos Andreou; George Papadopoulos; Vasiliki Vartela; Genovefa Kolovou; Flora Bacopoulou; Konstantinos Tsarouhas; Christina Kanaka-Gantenbein; Demetrios A Spandidos; Sophie I Mavrogeni
Journal:  Exp Ther Med       Date:  2020-04-29       Impact factor: 2.447

5.  Combined Brain-Heart Magnetic Resonance Imaging in Autoimmune Rheumatic Disease Patients with Cardiac Symptoms: Hypothesis Generating Insights from a Cross-sectional Study.

Authors:  George Markousis-Mavrogenis; Dimos D Mitsikostas; Loukia Koutsogeorgopoulou; Theodoros Dimitroulas; Gikas Katsifis; Panayiotis Argyriou; Dimitrios Apostolou; Stella Velitsista; Vasiliki Vartela; Dionysia Manolopoulou; Maria G Tektonidou; Genovefa Kolovou; George D Kitas; Petros P Sfikakis; Sophie I Mavrogeni
Journal:  J Clin Med       Date:  2020-02-06       Impact factor: 4.241

6.  Urine Biomarkers of Kidney Tubule Health and Incident CKD Stage 3 in Women Living With HIV: A Repeated Measures Study.

Authors:  Simon B Ascher; Rebecca Scherzer; Michelle M Estrella; Vasantha K Jotwani; Judy Shigenaga; Kimberly A Spaulding; Derek K Ng; Deborah Gustafson; Amanda B Spence; Anjali Sharma; Mardge H Cohen; Chirag R Parikh; Joachim H Ix; Michael G Shlipak
Journal:  Kidney Med       Date:  2021-04-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.